In parallel, activation of the Nrf2/ARE pathway and the upregulation of its important target enzymes HO-1 and NQQ-1 was also reported, indicating that hyperlipidemia by PA in non-adipose cells/tissues results in Nrf2/ARE activation [125]. The gene discussed is NFE2L2; the disease is hyperlipidemia.